$RAPP

2 theses

bullish 100%neutral 0%bearish 0%

Avg return (3d)

-2.3%

Win rate (3d)

0% (1 resolved)

1d 3d 1w 1m 3m 6m 1y

Past performance does not predict future results. Informational only, not investment advice.

Recent theses

Prices as of Oct 29, 4:01 PM ET

$RAPPSEC Form 4bullish

HEALY JAMES · Rapport Therapeutics, Inc. · 3h agono track record yet

Long 969,480 shares of RAPP

Bought 969,480 @ $21.00 avg · $20,359,080 · 2026-10-28

Form 4: HEALY JAMES bought RAPP

HEALY JAMES (Director at Rapport Therapeutics, Inc.) reported an open-market purchase of 969,480 shares of RAPP at an average $21.00, roughly $20,359,080, in a Form 4 filed 2026-10-30.

At post $25.05Now $24.21-3.4% since postedas of Oct 29, 4:01 PM ET

View filing on SEC.gov →

$RAPPSEC Form 4bullish

PAUL STEVEN M · Rapport Therapeutics, Inc. · 8d agono track record yet

Long 35,714 shares of RAPP

Bought 35,714 @ $27.28 avg · $974,278 · 2026-10-22

Form 4: PAUL STEVEN M bought RAPP

PAUL STEVEN M (Director at Rapport Therapeutics, Inc.) reported an open-market purchase of 35,714 shares of RAPP at an average $27.28, roughly $974,278, in a Form 4 filed 2026-10-22.

At post $26.53Now $24.21-8.7% since postedas of Oct 29, 4:01 PM ET

1d-2.3%

3d-2.3%

1w-8.7%

1m—

3m—

6m—

1y—

View filing on SEC.gov →

End of results.